ABQid
ABQid, founded in 2014, is an early-stage venture capital firm based in New Mexico that focuses on healthcare and technology companies. It offers a twelve-week accelerator program designed to rigorously mentor entrepreneurs, emphasizing customer discovery and validation. The program aims to help startups develop validated business models and prepare them for funding opportunities. By fostering a strong sense of integrity, accountability, and communication among entrepreneurs, ABQid seeks to enhance the local economy and contribute to the growth of a vibrant entrepreneurial ecosystem in Albuquerque.
Kane Robotics, Inc. specializes in developing advanced robotic systems tailored for the aerospace and defense industries. Founded in 2019 and based in Albuquerque, New Mexico, the company offers innovative automation solutions designed to enhance high-mix, low-volume production processes. Their product line includes cobot-based systems for sanding, grinding, finishing, drilling, epoxy dispensing, and machine tending. These standardized solutions aim to alleviate the burden of repetitive tasks on skilled workers, thereby increasing productivity and reducing operational costs for manufacturers in the aerospace and defense sectors. Additionally, Kane Robotics provides collaborative robot systems integration services to further support their clients' manufacturing needs.
X-Bow Launch Systems is dedicated to providing affordable access to orbit for commercial and government payloads.
Fetch is a flexible, on-demand delivery service that connects local communities and businesses with customers in need. It specializes in the fields of apps delivery, messaging, and mobile. It was founded in 2014 and headquartered in Santa Fe, New Mexico.
Peptineo represents the new face of biotechnology and bioengineering. By employing a systems-based approach, Peptineo technical solutions involve drug delivery combinations including “tunable” nano-carriers, engineered peptides, re-formulated pharmaceuticals, and as appropriate, recombinant proteins. Additionally, Peptineo is developing technologies that will greatly enhance and accelerate the drug discovery process.